Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gambogic acid 20172'

Search results for: 'gambogic acid 20172'

Items 31-40 of 52

Page
per page
  1. Levomefolate calcium
    A3552 Levomefolate calcium
    Summary: Artificial form of folate
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  2. L-Mimosine
    B4751 L-Mimosine
    Target: Hydroxylases
    Summary: iron chelator and prolyl 4-hydroxylase inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥1.98 mg/mL
  3. Ranitidine
    B1564 Ranitidine
    Target: Histamine H2 Receptors
    Summary: Histamine H2-receptor antagonist
      ≥17.54 mg/mL
  4. Allopurinol
    A8360 Allopurinol
    Target: Xanthine oxidoreductases
    Summary: Xanthine oxidase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.15 mg/mL
  5. Taxifolin
    N1842 Taxifolin
    Target: AdipoR2|Opioid receptors
      insoluble in H2O; ≥13.8 mg/mL
  6. Elvitegravir (GS-9137)
    A4070 Elvitegravir (GS-9137)
    Target: HIV Integrases
    Summary: HIV-1 integrase inhibitor,potent
      insoluble in H2O; insoluble in EtOH; ≥20.35 mg/mL
  7. Dioscin
    N1723 Dioscin
    Target: Autophagy
    Summary: Natural saponin with anti-tumor activities
      ≥35.55 mg/mL
  8. NPPB
    B6367 NPPB
    Target: Calcium-activated chloride channels (CaCC)|GPR35
    Summary: inhibitor of chloride channel
      insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL
  9. Adapalene
    A1267 Adapalene
    Target: RARs
    Summary: RARβ and RARγ agonist
      insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL
  10. Ki16425
    A1987 Ki16425
     4 Citation
    Target: LPA Receptors
    Summary: LPA receptor antagonist
      ≥23.75 mg/mL

Items 31-40 of 52

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 45item
  2. Natural Products 6item
  3. Peptides & Proteins 1 item
Specificity
  1. Selective 30item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Histone Deacetylases (HDACs) 4item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. Farnesoid X receptors (FXRs) 2item
  6. LPA Receptors 3item
  7. p38 1 item
  8. RARs 3item
  9. Aminopeptidases 1 item
  10. FAK 2item
  11. Topoisomerases 1 item
  12. Pyk2 2item
  13. AdipoR2 1 item
  14. Free Fatty Acid Receptors 1 item
  15. Autophagy 1 item
  16. Farnesyl Diphosphate Synthases 1 item
  17. HIV Integrases 1 item
  18. Calcium-activated chloride channels (CaCC) 1 item
  19. GPR35 1 item
  20. NPY Receptors 1 item
  21. RAR/RXR 1 item
  22. Opioid receptors 1 item
  23. Histamine H2 Receptors 1 item
  24. Monoamine oxidases (MAOs) 1 item
  25. TRP Channel 1 item
  26. Xanthine oxidoreductases 1 item
  27. fibrinolysis 1 item
  28. Hydroxylases 1 item
  29. Antioxidants 1 item
  30. GPR40 1 item
  31. KDM 1 item
  32. PPAR 1 item
  33. GABA receptors 1 item
  34. HCV polymerase 1 item
  35. Vitamin D receptors (VDRs) 1 item
  36. EAA receptor 1 item
  37. HIV 1 item
  38. Histone Acetyltransferases (HATs) 1 item
  39. Pregnane X receptor(PXR) 1 item
  40. FAAH 1 item
  41. prolactin secretion 1 item
  42. gonadotropin release 1 item
  43. PHF 1 item
  44. HMG 1 item
  45. HSD 1 item
  46. NS3/4a Proteases 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 5item
  5. Cancer 17item
  6. Colon Cancer 2item
  7. Colorectal Cancer 2item
  8. Epilepsy 1 item
  9. Glioblastoma 1 item
  10. Glioma 1 item
  11. HCV 1 item
  12. Hepatitis C 1 item
  13. Hepatocellular Carcinoma 2item
  14. HIV 1 item
  15. HIV Infections 2item
  16. Inflammation 1 item
  17. Inflammatory Diseases 1 item
  18. Lymphoma 1 item
  19. Myeloma 1 item
  20. Non-small Cell Lung Cancer 1 item
  21. Ovarian Cancer 1 item
  22. Pain Relief 1 item
  23. Pancreatic Cancer 6item
  24. Pentacyclic Triterpenoid 1 item
  25. Prostate Cancer 3item
  26. Renal Cancer 1 item
  27. Renal Cell Carcinoma 1 item
  28. Type 2 Diabetes 1 item